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Abstract: The articles in this special issue have demonstrated how unprecedented
transitions have come with both challenges and opportunities for health ﬁnancing.
Against the background of these challenges and opportunities, theWorking Group
on Health Financing at the Chatham House Centre on Global Health Security
laid out, in 2014, a set of policy responses encapsulated in 20 recommendations
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for how to make progress towards a coherent global framework for health
ﬁnancing. These recommendations pertain to domestic ﬁnancing of national
health systems, global public goods for health, external ﬁnancing for national
health systems and the cross-cutting issues of accountability and agreement on a
new global framework. Since the Working Group concluded its work, multiple
events have reinforced the group’s recommendations. Among these are the
agreement on the Addis Ababa Action Agenda, the adoption of the Sustainable
Development Goals, the outbreak of Ebola in West Africa and the release of the
Panama Papers. These events also represent new stepping stones towards a new
global framework.
Background and recommendations
Financing is at the centre of efforts to improve health and health systems. It is
only when resources are adequately, efﬁciently and equitably mobilised, pooled
and spent that all people can enjoy sustained progress towards universal
health coverage (UHC) and the full beneﬁts of global public goods for health
(GPGHs).
The articles in this special issue have demonstrated how unprecedented transi-
tions and new and persisting challenges shared by all countries put such progress
at risk, and do so particularly for low- and middle-income countries. These
transitions include profound changes in the global economy, changes in health
and risk factors for disease, and transformations of the institutional landscape of
global health. Despite important advances, persisting challenges include poor
health outcomes, poor access to health services and ﬁnancial risks to patients
stemming from out-of-pocket health service payments. These are compounded
by profound inequalities both between and within countries and by uneven
distribution of recent improvements.
Health ﬁnancing is central to meeting these grand challenges. But to do so
effectively, shortcomings in today’s approach to health ﬁnancing must be
addressed. As shown in Table 1, we believe the current approach must be revised
with respect to the domestic ﬁnancing of national health systems, the joint ﬁnan-
cing of GPGHs, and the external ﬁnancing of national health systems where
domestic capacity is inadequate.
Recent and ongoing transitions also come with unprecedented opportunities
to improve health ﬁnancing. Economic growth in many countries expands the
ﬁscal space for domestic spending on health. Projections up to 2035 forecast
real gross domestic product (GDP)-growth per year at 4–5, 4.3 and 4.2% for
low-, lower-middle and upper-middle-income countries, respectively (Jamison
et al., 2013). The proliferation of global health institutions provides an
opportunity to test a variety of ﬁnancing arrangements and draw lessons from
natural experiments. At the national level, governments demonstrate increasing
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willingness to invest in health and explore new ﬁnancial mechanisms in the
context of UHC.
Against the background of these challenges and opportunities, the Working
Group on Health Financing at the Chatham House Centre on Global Health
Security laid out a set of policy responses encapsulated in 20 recommendations for
how to make progress towards a coherent global framework for health ﬁnancing
(Panel 1) (Røttingen et al., 2014). While the recommendations speak to different
areas of health ﬁnancing, the Working Group emphasised how these areas
closely interact and how a comprehensive view is needed to attain coherence.
The recommendations also shared a common basis in justice, solidarity and
human rights.
Panel 1: recommendations
The recommendations offered by the Working Group fall into four categories.
Recommendations in the ﬁrst category describe what every government should
do to strengthen the domestic ﬁnancing of national health systems. These
recommendations cover resource mobilisation, pooling and use, and include key
targets for health expenditure. The recommendations in the second category
emphasise the additional responsibility governments have to help ﬁnance and
provide GPGHs, describe how this can be done, and point to how other actors
can facilitate the process. Recommendations in the third category describe how
governments and other donors can provide more and smarter external ﬁnancing
for health and offer a key target for governments’ contributions. Recommen-
dations in the ﬁnal category cut across the others. These recommendations pertain
to how accountability can be strengthened and how agreement can be sought to
make progress towards a coherent global framework.
Table 1. Shortcomings in today’s approach to health ﬁnancing
Domestic ﬁnancing of
national health systems
Joint ﬁnancing of global
public goods for health
External ﬁnancing for
national health systems
Insufﬁcient total funds
Over-reliance on out-of-pocket payments
Inadequate mechanisms to raise public ﬁnance
through effective tax and revenue systemsa
Rudimentary mechanisms for mandatory
prepayment with pooling of funds
Problematic priorities and inefﬁcient
health spending
Inadequate accountability
Insufﬁcient total funds
Inadequate focus among
countries
Inadequate institutions and
mechanisms for collective
action
Insufﬁcient total funds
Unsettled contribution norms
Volatility and uncertainty
Fungibility
Inadequate priority setting
Inadequate coordination
Inadequate accountability
Unclear rationale
aAdded to the list presented in the original report.
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Domestic ﬁnancing of national health systems
To strengthen domestic ﬁnancing of national health systems, the Working Group
concluded that
1. Every government should meet its primary responsibility for securing the health of
its own people. This involves a responsibility to oversee domestic ﬁnancing for
health and ensure that it is sufﬁcient, efﬁcient, equitable and sustainable.
2. Every government should commit to spend at least 5% of GDP on health and
move progressively towards this target, and every government should ensure
government health expenditures (GHE) per capita of at least $861 whenever
possible. Most middle-income countries should be able to reach both targets
without external support.
3. Every government should ensure that catastrophic and impoverishing out-
of-pocket payments (OOPPs) are minimised. Speciﬁcally, governments should
commit to the targets of OOPPs representing <20% of total health expenditures
(THE) and no OOPPs for priority services or for the poor.
4. Every government should improve revenue generation and achieve reduction of
OOPPs through effective, equitable and sustainable ways of increasing
mandatory prepaid pooled funds for health services. Individual contributions to
the pool(s) should primarily be based on capacity to pay and be progressive with
respect to income.
5. Every government should consider improved and innovative taxation as a means
to raise funds for health. Promising policies include the introduction or
strengthening of excise taxes related to tobacco, alcohol, sugar and carbon
emissions, and these should be combined with measures to increase tax
compliance, reduce illicit ﬂows and curb tax competition among countries. Other
sources of government revenue, particularly in countries rich in natural resources,
should also be explored.
6. Every government should ensure that mandatory prepaid pooled funds are used
with the aim of making progress towards UHC – that is, affordable access for
everyone. Speciﬁcally, every government should seek to ensure a universal health
system with full population coverage of comprehensive primary health care, high-
priority specialized care and public health measures, and should not prioritise
expanding coverage of a more comprehensive set of services for only some
privileged groups in society.
7. Every government, in collaboration with civil society, should formalize systematic
and transparent processes for priority-setting and for deﬁning a comprehensive
set of entitlements based on clear, well-founded criteria. Potential criteria
include those related to cost-effectiveness, severity and ﬁnancial risk protection.
The processes can build on the methods of health technology assessment and
multicriteria decision analysis, which can help translate evidence and explicit
values into policy decisions.
1 In the original report, this estimate was in 2012 $US terms. An update to 2015 $US terms based on
inﬂation and exchange rates generated the exact same ﬁgure, partly due to negative inﬂation rates in some
countries (McIntyre et al., 2017).
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8. Every government and other actor involved in the ﬁnancing or provision of
health care must continuously strive to improve efﬁciency. In particular, this will
require action on corruption and strategic purchasing, with continuous
assessment and active management of which services are purchased and what
providers and payment mechanisms are used.
Joint ﬁnancing of global public goods
To strengthen joint ﬁnancing of GPGHs, the Working Group concluded that
9. Every government should meet its key responsibility for the co-ﬁnancing of
GPGHs and take the necessary steps to correct the current undersupply of such
goods. Among key GPGHs are health information and surveillance systems, and
research and development for new technologies that speciﬁcally meet the needs
of the poor. Public funding for the latter purpose should be at least doubled
compared with the current level.
10. Every government should increase its support for new and existing institutions
charged with the ﬁnancing or provision of GPGHs. In particular, the World
Health Organization’s capacity to provide GPGHs should be enhanced and
adequate funds provided on a sustainable basis for that purpose.
11. Every government, international organisation, corporation and other key actor
should promote a global environment that enables all countries to pursue
government-revenue policies that can sufﬁciently ﬁnance their social sectors,
including health, education and welfare. This requires action on illicit ﬁnancial
ﬂows, tax havens, harmful tax competition and overexploitation of natural
resources.
External ﬁnancing for national health systems
To strengthen external ﬁnancing for national health systems, the Working Group
concluded that
12. Every country with sufﬁcient capacity should contribute with external ﬁnancing
for health. Determination of capacity should partly depend on GDP per capita.
Net contributing countries should include all high-income countries and most
upper-middle-income countries and not only member countries of the
Organisation for Economic Co-operation and Development’s Development
Assistance Committee (OECD-DAC).
13. High-income countries should commit to provide external ﬁnancing for health
equivalent to at least 0.15% of GDP. Most upper-middle-income countries
should commit to progress towards the same contribution rate.
14. Every provider of external ﬁnancing for health, including contributing countries
and international organisations, should establish clear, well-founded and
publicly available criteria to guide the allocation of resources. These should be
the outcome of broad, deliberative processes with input from key stakeholders,
including civil society in contributing and recipient countries.
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15. Every provider of external ﬁnancing for health should align its support with
recipient-country government priorities to the greatest extent possible. This calls
for strong adherence to the Paris Declaration on Aid Effectiveness and the Accra
Agenda for Action. In particular, providers of external ﬁnancing for health
should encourage and comply with national plans and strategies, improve
transparency and monitoring of disbursements and results, and help to build
domestic governance and institutional capacity.
16. All providers of external ﬁnancing for health should strive to strengthen
coordination among themselves and with each recipient country, in order to
improve efﬁciency as well as equity. In particular, they should encourage and
comply with country-led division of labour, harmonise procedures, increase the
use of joint and shared arrangements, and improve information sharing.
17. Every government should actively assess the existing mechanisms for pooling of
external funds for health – including the Global Fund to Fight AIDS,
Tuberculosis and Malaria; Gavi, the Vaccine Alliance (Gavi); and the World
Bank’s health trust funds – and consider the feasibility of broader mandates,
mergers and increased global pooling with the aim of improving efﬁciency and
equity.
Accountability and agreement
Strong accountability mechanisms and global agreement on responsibilities,
targets and strategies will facilitate the implementation of the needed policy
responses and a coherent global framework. The Working Group concluded that
18. Every government and other actor involved in domestic or external ﬁnancing or
in the provision of health services should seek to strengthen accountability at
global, national and local levels. This should be done by improving transparency
about decisions, resource use and results, by improving monitoring and data
collection and by ensuring critical evaluation of information with effective
feedback into policy making. Accountability should also be strengthened
through active monitoring by civil society and by ensuring the broad
participation of stakeholders throughout the policy process.
19. Every government and other key actor should seek to ensure that health
and UHC are central goals and yardsticks in the post-2015 development
agenda. These actors should also seek to ensure that the responsibilities, targets
and strategies of a coherent global framework for health ﬁnancing are integrated
to the fullest extent possible. Moreover, the agenda should make clear
that health is important both for its own sake and for the sake of other goals,
including poverty eradication, economic growth, better education and
sustainability.
20. All stakeholders should enter into a process of seeking global agreement on key
responsibilities, targets and strategies for health ﬁnancing – including on the
mechanisms for monitoring and enforcement – in order to expedite the
implementation of a coherent global ﬁnancing framework. In the short term,
consultation on the post-2015 development agenda is one useful arena for
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building consensus, and the agenda itself can be a valuable commitment
device. In the longer term, a more speciﬁc process should be devised in one or
more relevant forums, such as the UN General Assembly, the World Health
Assembly, World Bank/International Monetary Fund, or a high-level stand-
alone meeting.
Recent developments and the way forward
Since the Working Group concluded its work, multiple events have reinforced the
group’s recommendations. The Third International Conference on Financing for
Development took place in July 2015 and resulted in the Addis Ababa Action
Agenda (United Nations (UN), 2015a). Two months later the 2030 Agenda for
Sustainable Development, with the Sustainable Development Goals (SDGs), was
adopted in New York (United Nations (UN), 2015b). Both endorsed UHC. The
Addis Ababa Action Agenda committed governments to a new social compact, to
provide ﬁscally sustainable and nationally appropriate social protection systems
and measures for all, and to achieve UHC. In the 2030 Agenda for Sustainable
Development, SDG 3 is to ‘[e]nsure healthy lives and promote well-being for all at
all ages’, and one of its targets is to achieve UHC.
At both meetings it was clear that trillions, not billions, of dollars would be
required to accomplish the SDGs. One estimate suggests incremental public and
private spending needs in low- and lower-middle-income countries of 1.4 trillion
(US$ 2013) per year, of which $68–$87 billion (all public) is in the area of health
(Schmidt-Traub, 2015). While mobilising these resources would be a huge step
forward, it will at least not in the short term close all shortfalls from the target of
$86 in GHE per capita, which was one key target proposed by the Working
Group. In 2012, these shortfalls amounted to a global ﬁnancing gap of $196
billion (Røttingen et al., 2014). Recent projections also suggest that even by 2040,
only seven of today’s low-income countries will have reached that target
(Dieleman et al., 2016).
All this underscores the need for bold action on health ﬁnancing. The need for
action has recently also been demonstrated in the speciﬁc areas of domestic
ﬁnancing, ﬁnancing of GPGHs and external ﬁnancing.
Domestic ﬁnancing of health systems
The Addis Ababa Action Agenda emphasises the centrality of domestic resource
mobilisation in development ﬁnancing and for achieving the SDGs. In particular,
governments committed to fairer, more transparent and more efﬁcient tax systems
and to scale-up international tax cooperation, which is in line with the analyses
presented in this supplement (McCoy et al., 2017). The 2030 Agenda for Sustain-
able Development also underscores that each country has primary responsibility
for its own economic and social development. One of the targets highlighted in the
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Agenda is to strengthen domestic resource mobilisation, and the scope for doing
this is thoroughly examined in this special issue (Elovainio & Evans, 2017;
Meheus and McIntyre, 2017). Concurrently, there has been a number of calls for
better use of resources. In May 2014, the World Health Assembly afﬁrmed the
importance of national systems for health technology assessment with systematic
use of evidence (World Health Organization [WHO], 2014), and the overarching
theme of the 2016 Prince Mahidol Award Conference was ‘priority setting for
universal health coverage’ (Prince Mahidol Award Conference, 2016).
Joint ﬁnancing of global public goods
Two transnational health threats have come more prominently to the fore over
the last two years. Ebola and later Zika have underscored the constant threat of
emerging infectious diseases and the need for a much stronger system for preventing,
detecting, and responding to epidemics (Moon et al., 2015; CHRF Commission,
2016; High-Level Panel on the Global Response to Health Crises, 2016). At the
same time, the challenge of antimicrobial resistance has attracted more attention
from policy makers, and, in May 2015, the World Health Assembly endorsed a
global action plan to tackle resistance (World Health Organization (WHO), 2015a;
Årdal et al., 2016). The Global Health Security Agenda, launched in February 2014,
has also helped raising awareness about epidemics as well as antimicrobial resistance
(Global Health Security Agenda, 2016).
Over the last two years, the World Health Assembly has also explored options
to strengthen research and development for neglected diseases (WHO, 2014,
2015b). Various pooled funds have been proposed for addressing GPGHs. One is
a global biomedical R&D fund for concurrently addressing emerging infectious
diseases, antimicrobial resistance and neglected diseases (Balasegaram et al.,
2015). Another is a fund for development of vaccines or biomedical counter-
measures to epidemics more generally (Plotkin et al., 2015; CHRF Commission,
2016; High-Level Panel on the Global Response to Health Crises, 2016), and in
2016 the Coalition for Epidemic Preparedness Innovations (CEPI) was established
to help ﬁnance and coordinate the development of new vaccines to prevent and
contain infectious disease epidemics (CEPI, 2016). These and other systems to
handle transnational health threats or ensure development of essential techno-
logies need to be considered global goods (Moon et al., 2017).
Another, broad set of GPGHs comprise the factors helping create an enabling
environment for health ﬁnancing. The 2030 Agenda for Sustainable Development
highlights tax collaboration, macroeconomic stability and equitable trade rules,
and one target is to signiﬁcantly reduce illicit ﬁnancial ﬂows (UN, 2015b).
The recent Panama Papers have demonstrated how today’s environment is far
from an enabling one and underscored the importance of targeting ﬁnancial
secrecy (The International Consortium of Investigative Journalists, 2016).
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External ﬁnancing for national health systems
While the spotlight is increasingly being put on domestic ﬁnancing and global
public goods, external ﬁnancing will remain critical for many years ahead.
Low-income countries in particular will be unable to achieve the SDGs through
domestic means alone. One estimate indicates a gap of $152–$163 billion per year
in these countries (Schmidt-Traub, 2015). This intensiﬁes existing challenges
in resource mobilisation as well as use. Both the Addis Ababa Action Agenda
and the 2030 Agenda for Sustainable Development highlight the 0.7% ofﬁcial
development assistance (ODA)/GNI target, but in 2015 only six countries reached
this target (OECD, 2016a), and few additional countries are on track to reach
this target anytime soon. While the Addis Ababa Action Agenda reafﬁrmed the
European Union’s commitment to achieve the target, this was done within the
timeframe of 2030 (UN, 2015a).
With respect to the allocation of external funds, the Addis Ababa Action
Agenda and the 2030 Agenda for Sustainable Development call for priority to the
countries in greatest need and to the least developed countries (LDCs) (UN, 2015a,
2015b). However, while total ODA increased in 2014, the amount going to
LDCs fell (OECD, 2016b). To get a better understanding of country needs and
the allocation of external ﬁnancing for health, the Global Fund and eight other
co-conveners recently ran the Equitable Access Initiative (Global Fund, 2016).
This initiative demonstrated the impact of going beyond gross national product
GNI per capita and considering countries’ health needs and governments’ ﬁscal
capacity, and it recommended donors to take these factors into account when
allocating funds. The need for a multi-dimensional set of allocation criteria has also
recently been stressed by many others (Burgett et al., 2016), and is thoroughly
discussed in this special issue (Moon &Omole, 2017 and three papers by Ottersen
et al. in this series).
The SDGs and other recent developments have also intensiﬁed questions about
the allocation of funds across thematic areas. This is the case, for example, for
priorities across the three health areas of the Millennium Development Goals
(MDGs): maternal health, child health and the ‘big three’ infectious diseases
(HIV/AIDS, malaria and tuberculosis). While the Global Fund has attracted
funding towards the latter, the new Global Financing Facility (World Bank, 2015)
may tilt the balance towards maternal and child health.
At the same time, the broader SDG agenda asks whether higher priority should be
assigned to areas beyond the MDGs, including non-communicable diseases (NCDs).
The SDGs also intensiﬁes the question about the role of general health system
strengthening and the pursuit of UHC in all this. Similarly, there is a question about to
what extent, if any, external funds should be shifted towards GPGHs. Several donors
have increased their attention to NCDs, health systems or both, and some donors
have recently turned towards research for neglected diseases and antimicrobial
resistance (HM Treasury, 2015). Moreover, Ebola has exposed the great need for
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support of national capacities to prevent, detect and respond to outbreaks (CHRF
Commission, 2016). In this complex landscape, donors need to develop clear and
well-founded criteria to guide the allocation of resources, and the criteria should be
made publicly available to a greater extent than is the case today.
Way forward
The many recent developments underscore the Working Group’s recommen-
dations, the need to revise today’s approach to domestic ﬁnancing, the ﬁnancing
of GPGHs, and external ﬁnancing, and the need to consider these areas holistically
and seek a coherent global framework. Fortunately, the same developments offer
valuable starting points for revision. Supplemented with clearer responsibilities
and robust accountability mechanisms, the Addis Ababa Action Agenda and the
2030 Agenda for Sustainable Development can help facilitate a new global
framework for health ﬁnancing. Themomentum of UHC draws attention towards
the ﬁnancing side of health systems and towards a systems perspective over a focus
on single diseases. At the same time, Ebola and Zika may create a policy window
where the neglected area of GPGHs can be better addressed. The Addis Ababa
Action Agenda and the 2030 Agenda for Sustainable Development also highlight
how the health sector can catalyse progress in other sectors and how external
ﬁnancing can catalyse domestic ﬁnancing and the ﬁnancing of GPGHs.
Overall, the need for a coherent global framework for health ﬁnancing has
become even clearer, and new stepping stones have emerged. These comes with
opportunities not to be missed.
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